EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PDS Biotechnology's enterprise value is $50.75 Mil.
PDS Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, PDS Biotechnology's EV-to-Revenue for today is .
The historical rank and industry rank for PDS Biotechnology's EV-to-Revenue or its related term are showing as below:
PDSB's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.16 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for PDS Biotechnology's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PDS Biotechnology's EV-to-Revenue
For the Biotechnology subindustry, PDS Biotechnology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PDS Biotechnology's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PDS Biotechnology's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where PDS Biotechnology's EV-to-Revenue falls into.
PDS Biotechnology's current Enterprise Value is $50.75 Mil.
PDS Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PDS Biotechnology's share price for today is $1.58.
PDS Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PDS Biotechnology EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of PDS Biotechnology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PDSB has been successfully added to your 